期刊文献+

我院2011-2013年国家基本药物应用分析 被引量:1

Analysis of the Application of National Essential Medicines in Our Hospital from 2011 to 2013
原文传递
导出
摘要 目的:促进国家基本药物在临床的合理使用,为进一步贯彻实施新版《国家基本药物目录》提供参考。方法:从医院信息系统(HIS)中调取我院2011-2013年在用国家基本药物使用数据,就药品名称、数量、金额等进行统计分析。结果:2011-2013年我院配备的国家基本药物品种数分别为179、183和187种,分别占2012年版《国家基本药物目录》品种数的34.42%、35.19%和35.96%,销售金额分别占全院当年药品销售总金额的19.49%、17.56%和18.17%;销售金额排序前3位的国家基本药物类别主要为调节水、电解质及酸碱平衡药,抗微生物药和抗肿瘤药;西药类国家基本药物品种中氯化钠注射液和葡萄糖注射液连续3年占据销售金额排序前2位,而中成药类国家基本药物品种中参麦注射液始终排名首位。结论:近年我院使用的心血管系统国家基本药物所占比例较低,与临床实际需求仍有差距。各类型国家基本药物的用药品种及销售金额相对集中,国家基本药物覆盖率和使用率还有待进一步提高。 OBJECTIVE:To promote the rational use of national essential medicines in clinic,and to provide reference for the further implementation of new National Essential Medicines List. METHODS:The application data of national essential medicines in our hospital from 2011 to 2013 were collected from hospital information system(HIS). The drug name,amount and sum were analyzed statistically. RESULTS:From 2011 to 2013,the kinds of national essential medicines were 179,183 and 187 in our hospital,accounted for 34.42%,35.19% and 35.96% of new National Essential Medicines List,respectively;the consumption sum of national essential medicines accounted for 19.49%,17.56% and 18.17% of total in our hospital,respectively;the top 3 national essential medicines were regulating water,electrolyte and acid-base balance regulation drugs,anti-microbial drugs and anti-cancer drugs in the list of consumption sum;Sodium chloride injection and Glucose injection were the top 2 consumption sum of western medicines in national essential medicines;and Shenmai injection still held the top 1 in Chinese patent medicine. CONCLUSIONS:In recent years,the proportion of national essential medicines used in cardiovascular system in our hospital is low,and there is still a gap between the clinical actual demands. The varieties and consumption sum of national essential medicines for each category is relatively concentrated,the national essential medicines coverage rate and utilization rate remains to be further improved.
机构地区 黄石市中心医院
出处 《中国药房》 CAS 北大核心 2016年第9期1207-1209,共3页 China Pharmacy
关键词 国家基本药物 数量 金额 应用分析 National essential medicines Amount Sum Analysis of the application
  • 相关文献

参考文献9

二级参考文献54

  • 1黄萍,何明坤,苏常春,王衍慧,王艳,范伟.参麦注射液治疗糖尿病周围神经病变的临床研究[J].中国中医药科技,2007,14(3):152-153. 被引量:22
  • 2王丽,尹桃,朱敏文.参麦注射液不良反应回顾性研究[J].中南药学,2007,5(3):273-276. 被引量:31
  • 3Gamelin E, Gamelin L, Bossi L, et al. Clinical aspects and molecular basis of oxalip latin neurotoxicity: current management and development of preventive measures[J]. Semin Oncol, 2002,29 (5 Suppl 15 ) : 21.
  • 4蔡雄鑫.临床神经电生理学[M].第1版.成都:西南交通大学出版社,1992:78-103.
  • 5Jamieson SM, Liu J, Hsu T, et al. Paclitaxel induces nucleolar enlargement in dorsal root ganglion neurons in vivo reducing oxalip latintoxicity[J]. Br J Cancer, 2003,88 (12):1 942.
  • 6Apfel SC. Nerve growth factor for the treatment of diabetic neuropathy: what went wrong, what went right, and what does the future hold?[J], lnt Rev Neurobiol, 2002,50(23):393.
  • 7Svensson P, Cairns BE, Wang K, et al. Injection of ner- ve growth factor into human masseter muscle evokes lo- ng-lasting mechanical allodynia and hyperalgesia[J].Pain, 2003,104(1-2) : 241.
  • 8卫生部.《国家基本药物目录·基层医疗卫生机构配备使用部分》(2009版)说明.2009.
  • 9国家药品不良反应监测中心《关于发布2011年重点品种监测的通知》(监测与评价综[2011]58号).
  • 10王永铭,李端.临床药理学.第二版[M].上海:上海医科大学出版社,1999:39.

共引文献63

同被引文献5

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部